These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


570 related items for PubMed ID: 11162132

  • 1. Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine.
    Hein TW, Wang W, Zoghi B, Muthuchamy M, Kuo L.
    J Mol Cell Cardiol; 2001 Feb; 33(2):271-82. PubMed ID: 11162132
    [Abstract] [Full Text] [Related]

  • 2. Adenosine A(2A) receptors mediate coronary microvascular dilation to adenosine: role of nitric oxide and ATP-sensitive potassium channels.
    Hein TW, Belardinelli L, Kuo L.
    J Pharmacol Exp Ther; 1999 Nov; 291(2):655-64. PubMed ID: 10525085
    [Abstract] [Full Text] [Related]

  • 3. Requisite roles of A2A receptors, nitric oxide, and KATP channels in retinal arteriolar dilation in response to adenosine.
    Hein TW, Yuan Z, Rosa RH, Kuo L.
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2113-9. PubMed ID: 15914631
    [Abstract] [Full Text] [Related]

  • 4. cAMP-independent dilation of coronary arterioles to adenosine : role of nitric oxide, G proteins, and K(ATP) channels.
    Hein TW, Kuo L.
    Circ Res; 1999 Oct 01; 85(7):634-42. PubMed ID: 10506488
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms involved in increased sensitivity to adenosine A(2A) receptor activation and hypoxia-induced vasodilatation in porcine coronary arteries.
    Hedegaard ER, Nielsen BD, Mogensen S, Rembold CM, Frøbert O, Simonsen U.
    Eur J Pharmacol; 2014 Jan 15; 723():216-26. PubMed ID: 24309216
    [Abstract] [Full Text] [Related]

  • 6. Role of K+ channels in A2A adenosine receptor-mediated dilation of the pressurized renal arcuate artery.
    Prior HM, Yates MS, Beech DJ.
    Br J Pharmacol; 1999 Jan 15; 126(2):494-500. PubMed ID: 10077243
    [Abstract] [Full Text] [Related]

  • 7. Functional characterization of coronary vascular adenosine receptors in the mouse.
    Flood A, Headrick JP.
    Br J Pharmacol; 2001 Aug 15; 133(7):1063-72. PubMed ID: 11487517
    [Abstract] [Full Text] [Related]

  • 8. Adenosine mediates nitric-oxide-independent renal vasodilation by activation of A2A receptors.
    Rump LC, Jabbari-T J, von Kügelgen I, Oberhauser V.
    J Hypertens; 1999 Dec 15; 17(12 Pt 2):1987-93. PubMed ID: 10703900
    [Abstract] [Full Text] [Related]

  • 9. Antagonism of coronary artery relaxation by adenosine A2A-receptor antagonist ZM241385.
    Arif Hasan AZ, Abebe W, Mustafa SJ.
    J Cardiovasc Pharmacol; 2000 Feb 15; 35(2):322-5. PubMed ID: 10672868
    [Abstract] [Full Text] [Related]

  • 10. Enhanced adenosine A2A receptor facilitation of synaptic transmission in the hippocampus of aged rats.
    Rebola N, Sebastião AM, de Mendonca A, Oliveira CR, Ribeiro JA, Cunha RA.
    J Neurophysiol; 2003 Aug 15; 90(2):1295-303. PubMed ID: 12904509
    [Abstract] [Full Text] [Related]

  • 11. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
    Sun WC, Moore JN, Hurley DJ, Vandenplas ML, Linden J, Cao Z, Murray TF.
    Vet Immunol Immunopathol; 2008 Jan 15; 121(1-2):91-100. PubMed ID: 17913243
    [Abstract] [Full Text] [Related]

  • 12. Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists.
    Gao Z, Li Z, Baker SP, Lasley RD, Meyer S, Elzein E, Palle V, Zablocki JA, Blackburn B, Belardinelli L.
    J Pharmacol Exp Ther; 2001 Jul 15; 298(1):209-18. PubMed ID: 11408544
    [Abstract] [Full Text] [Related]

  • 13. Cellular signalling pathways mediating dilation of porcine pial arterioles to adenosine A₂A receptor activation.
    Hein TW, Xu W, Ren Y, Kuo L.
    Cardiovasc Res; 2013 Jul 01; 99(1):156-63. PubMed ID: 23539502
    [Abstract] [Full Text] [Related]

  • 14. Cellular mechanisms by which adenosine induces vasodilatation in rat skeletal muscle: significance for systemic hypoxia.
    Bryan PT, Marshall JM.
    J Physiol; 1999 Jan 01; 514 ( Pt 1)(Pt 1):163-75. PubMed ID: 9831724
    [Abstract] [Full Text] [Related]

  • 15. Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism.
    Wyatt AW, Steinert JR, Wheeler-Jones CP, Morgan AJ, Sugden D, Pearson JD, Sobrevia L, Mann GE.
    FASEB J; 2002 Oct 01; 16(12):1584-94. PubMed ID: 12374781
    [Abstract] [Full Text] [Related]

  • 16. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells.
    Chern Y, Lai HL, Fong JC, Liang Y.
    Mol Pharmacol; 1993 Nov 01; 44(5):950-8. PubMed ID: 8246918
    [Abstract] [Full Text] [Related]

  • 17. Activation of phosphodiesterase IV during desensitization of the A2A adenosine receptor-mediated cyclic AMP response in rat pheochromocytoma (PC12) cells.
    Chang YH, Conti M, Lee YC, Lai HL, Ching YH, Chern Y.
    J Neurochem; 1997 Sep 01; 69(3):1300-9. PubMed ID: 9282956
    [Abstract] [Full Text] [Related]

  • 18. Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase.
    Kleppisch T, Nelson MT.
    Proc Natl Acad Sci U S A; 1995 Dec 19; 92(26):12441-5. PubMed ID: 8618917
    [Abstract] [Full Text] [Related]

  • 19. The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells.
    Kudlacek O, Just H, Korkhov VM, Vartian N, Klinger M, Pankevych H, Yang Q, Nanoff C, Freissmuth M, Boehm S.
    Neuropsychopharmacology; 2003 Jul 19; 28(7):1317-27. PubMed ID: 12784121
    [Abstract] [Full Text] [Related]

  • 20. Adenosine A2A receptor modulation of juvenile female rat skeletal muscle microvessel permeability.
    Wang J, Huxley VH.
    Am J Physiol Heart Circ Physiol; 2006 Dec 19; 291(6):H3094-105. PubMed ID: 16815983
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.